Kullman Ellen Jamison

SEC source: 0001303141-26-000008 · wk-form4_1790626337.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,081

F1 · shares: Represents a grant of 419 deferred stock units ("DSUs"). The DSUs vest in full on the first anniversary of the annual meeting of shareholders of Dell Technologies Inc. held on June 25, 2026, contingent on the reporting person's continued service on such vesting date.

SEC source: 0000318154-26-000107 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,535.9807

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 2,121 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · derivative · entry 10

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Stock · 126,258 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options are fully vested.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · derivative · entry 9

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,258

Underlying: Class C Common Stock · 15,287 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options are fully vested.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · derivative · entry 8

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Stock · 8,801 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options are fully vested.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 7

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,662

F3 · price: The price reported in Column 4 represents a weighted average sales price of $145.4237. These shares were sold in multiple transactions at prices ranging from $145.04 to $145.94, inclusive.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 6

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,789

F2 · price: The price reported in Column 4 represents a weighted average sales price of $144.5085. These shares were sold in multiple transactions at prices ranging from $144.04 to $145.03, inclusive.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 5

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 4

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,662

F1 · price: The price reported in Column 4 represents a weighted average sales price of $145.7164. These shares were sold in multiple transactions at prices ranging from $145.60 to $145.83, inclusive. The reporting person undertakes to provide to Dell Technologies Inc., any security holder of Dell Technologies Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnotes 1 through 3.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 3

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 2

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,662

SEC source: 0001303141-26-000006 · wk-form4_1773173363.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001303141-26-000003 · wk-form4_1769031151.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,798

Underlying: Common Stock, par value $0.01 per share · 364 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2025 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2025 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2025 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001303141-25-000009 · wk-form4_1760732164.xml · derivative · entry 3

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,801

Underlying: Class C Common Stock · 79,806 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options are fully vested.

SEC source: 0001303141-25-000009 · wk-form4_1760732164.xml · nonDerivative · entry 2

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,662

F1 · price: The price reported in Column 4 represents a weighted average sales price of $153.5578. These shares were sold in multiple transactions at prices ranging from $153.245 to $153.92, inclusive. The reporting person undertakes to provide to Dell Technologies Inc., any security holder of Dell Technologies Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001303141-25-000009 · wk-form4_1760732164.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,468

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001303141-25-000007 · wk-form4_1759437104.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,662

F1 · shares: Represents a grant of 1,587 deferred stock units ("DSUs"). The DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 26, 2025, contingent on the reporting person's continued service on such vesting date.

SEC source: 0001127602-25-015859 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,466.9807

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 1,717 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001303141-25-000002 · wk-form4_1737496234.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,434

Underlying: Common Stock, par value $0.01 per share · 570 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2024 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2024 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2024 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001571996-24-000115 · wk-form4_1726863793.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,075

F1 · shares: Represents a grant of 1,939 deferred stock units ("DSUs"). The DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 27, 2024, contingent on the reporting person's continued service on such vesting date.

F1 · price: Represents a grant of 1,939 deferred stock units ("DSUs"). The DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 27, 2024, contingent on the reporting person's continued service on such vesting date.

SEC source: 0001127602-24-017814 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,299.9807

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

F2 · balance_after: These shares include 1,359 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001303141-24-000002 · wk-form4_1705698411.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,864

Underlying: Common Stock, par value $0.01 per share · 927 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2023 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2023 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2023 Annual Grant. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001062993-23-018703 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,136

F1 · shares: Represents a grant of 821 restricted stock units ("RSUs") and 3,964 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 20, 2023, contingent on the reporting person's continued service on such vesting date.

F1 · price: Represents a grant of 821 restricted stock units ("RSUs") and 3,964 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 20, 2023, contingent on the reporting person's continued service on such vesting date.

SEC source: 0001127602-23-016639 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,208.9807

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 987 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-23-004264 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,937

Underlying: Common Stock, par value $0.01 per share · 1,089 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2022 Annual Grant and fourth quarter 2022 Annual Retainer and Committee Chair Fee. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2022 Annual Grant and fourth quarter 2022 Annual Retainer and Committee Chair Fee. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2022 Annual Grant and fourth quarter 2022 Annual Retainer and Committee Chair Fee. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001127602-22-025334 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,112.9807

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 830 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-22-054270 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,848

Underlying: Common Stock, par value $0.01 per share · 101 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001062993-22-019877 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,351

F1 · shares: Represents a grant of 677 shares of Class C Common Stock, 1,523 restricted stock units ("RSUs") and 6,595 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 27, 2022, contingent on the reporting person's continued service on such vesting date.

F1 · price: Represents a grant of 677 shares of Class C Common Stock, 1,523 restricted stock units ("RSUs") and 6,595 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 27, 2022, contingent on the reporting person's continued service on such vesting date.

F2 · balance_after: On November 1, 2021, the Issuer completed a special distribution of all of the shares of common stock of its former subsidiary, VMware, Inc., that it beneficially owned to its stockholders on a pro rata basis (the "Transaction"). In connection with the Transaction, the Issuer implemented an equitable adjustment to outstanding equity awards held by participants in the Issuer's 2013 Stock Incentive Plan in accordance with the terms of the plan, as a result of which (a) 541 RSUs previously reported by the reporting person were adjusted to a total of 1,065 RSUs, (b) 21,950 DSUs previously reported by the reporting person were adjusted to a total of 43,207 DSUs and (c) 138,584 options to purchase Class C Common Stock of the Issuer ("stock options") previously reported by the reporting person were adjusted to a total of 272,736 stock options. The adjusted exercise prices of the stock options range from $13.60 to $31.14, inclusive.

SEC source: 0001127602-22-020848 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,814.6749

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 754 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-22-042856 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,747

Underlying: Common Stock, par value $0.01 per share · 99 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001127602-22-015179 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,607.8165

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 678 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-22-013336 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,752.8165

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 678 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-22-024964 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,648

Underlying: Common Stock, par value $0.01 per share · 95 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's 2022 Annual Retainer and Committee Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001209191-22-004440 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,553

Underlying: Common Stock, par value $0.01 per share · 1,095 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2021 Annual Grant and fourth quarter 2021 Annual Retainer and Committee Chair Fee. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2021 Annual Grant and fourth quarter 2021 Annual Retainer and Committee Chair Fee. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Represents Restricted Stock Units ("RSUs") granted for the Reporting Person's 2021 Annual Grant and fourth quarter 2021 Annual Retainer and Committee Chair Fee. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001127602-21-028760 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,477.0751

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 543 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-21-061152 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock, par value $0.01 per share · 76 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001123292-21-001338 · edgar.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,775

F1 · shares: Represents a grant of 241 shares of Class C Common Stock, 541 restricted stock units ("RSUs") and 2,341 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 22, 2021, contingent on the reporting person's continued service on such vesting date.

F1 · price: Represents a grant of 241 shares of Class C Common Stock, 541 restricted stock units ("RSUs") and 2,341 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 22, 2021, contingent on the reporting person's continued service on such vesting date.

SEC source: 0001127602-21-023489 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,263.0425

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 481 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-21-046932 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,382

Underlying: Common Stock, par value $0.01 per share · 84 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001127602-21-017468 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,930.618

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 431 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-21-015043 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,093.618

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 431 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001209191-21-026960 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,298

Underlying: Common Stock, par value $0.01 per share · 93 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Restricted Stock Units ("RSUs") granted in respect of the Reporting Person's Annual Retainer and Chair Fee are granted quarterly, in arrears. Shares of the Issuer's common stock underlying these RSUs will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001127602-21-004468 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,907.9979

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 381 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0000899243-21-002950 · doc4.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,637

Underlying: Common Stock, par value $0.01 per share · 1,637 shares

Expires not disclosed

F1 · derivative.exercise_price: 1,205 shares of the Issuer's common stock underlying these Restricted Stock Units will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors, and 432 shares will deliver in the year following the year of the Reporting Person's retirement.

F1 · derivative.exercise_date: 1,205 shares of the Issuer's common stock underlying these Restricted Stock Units will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors, and 432 shares will deliver in the year following the year of the Reporting Person's retirement.

F1 · derivative.expiration_date: 1,205 shares of the Issuer's common stock underlying these Restricted Stock Units will be delivered approximately 90 days after the retirement of the Reporting Person from the Issuer's Board of Directors, and 432 shares will deliver in the year following the year of the Reporting Person's retirement.

SEC source: 0001127602-20-028203 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,846.0717

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 336 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001123292-20-001112 · edgar.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,652

F1 · shares: Represents a grant of 380 shares of Class C Common Stock, 855 restricted stock units ("RSUs") and 3,708 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 29, 2020, contigent on the reporting person's continued service on such vesting date.

F1 · price: Represents a grant of 380 shares of Class C Common Stock, 855 restricted stock units ("RSUs") and 3,708 deferred stock units ("DSUs"). The RSUs and DSUs vest in full on the first anniversary of the annual meeting of stockholders of Dell Technologies Inc. held on June 29, 2020, contigent on the reporting person's continued service on such vesting date.

SEC source: 0001127602-20-022622 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,663.297

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 294 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-20-015855 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,380.1559

F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 252 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

SEC source: 0000769993-20-000018 · ownershipdoc01142020021944.xml · derivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,761

Underlying: Common Stock, par value $0.01 per share · 2,371 shares

Expires not disclosed

F1 · derivative.exercise_price: Shares of the Issuer's common stock underlying these Restricted Stock Units will be delivered in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: Shares of the Issuer's common stock underlying these Restricted Stock Units will be delivered in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: Shares of the Issuer's common stock underlying these Restricted Stock Units will be delivered in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

SEC source: 0001127602-19-031963 · form4.xml · nonDerivative · entry 1

Kullman Ellen Jamison · CIK 0001303141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,335

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.

F2 · balance_after: These shares include 184 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.